logo

Fennec Pharmaceuticals Inc (FENC)



Trade FENC now with
  Date
  Headline
11/29/2021 6:24:08 AM Fennec Pharma Expects To Receive CRL From FDA For PEDMARK NDA
11/10/2021 6:05:25 AM Fennec Pharma Q3 Loss Per Share $0.16 Vs Loss $0.24 Last Year
8/10/2021 6:12:12 AM Fennec Pharma Q2 Net Loss $4.0 Mln Or $0.15/Shr Vs Loss $4.8 Mln Or $0.21/Shr Last Year
6/24/2021 6:12:33 AM Fennec Pharma Amends Existing Senior Debt Facility With Life Sciences At Bridge Bank Increasing The Size To $20 Mln
6/22/2021 6:31:52 AM Fennec Pharma: FDA Accepts Filing The Resubmission Of NDA For PEDMARK
5/10/2019 8:39:36 AM Wedbush Is Cutting Fennec Pharmaceuticals Inc (FENC) FY19 Estimate To -0.61 From 2.74
5/10/2019 8:39:20 AM Wedbush Is Cutting Fennec Pharmaceuticals Inc (FENC) Q4 19 Estimate To -0.17 From 3.37
5/10/2019 8:39:07 AM Wedbush Is Increasing Fennec Pharmaceuticals Inc (FENC) Q3 19 Estimate To -0.16 From -0.23
5/10/2019 8:38:53 AM Wedbush Is Raising Fennec Pharmaceuticals Inc (FENC) Q2 19 Estimate To -0.15 From -0.21
5/10/2019 8:38:18 AM Wedbush Reiterates Fennec Pharmaceuticals Inc (FENC) At Outperform With $16 Price Target
3/14/2019 7:44:51 AM Wedbush Reiterates Fennec Pharmaceuticals Inc (FENC) At Outperform With $16 Price Target
8/14/2018 6:54:25 AM Wedbush Is Cutting Fennec Pharmaceuticals Inc (FENC) FY18 Estimate To -0.54 From -0.42
8/14/2018 6:54:12 AM Wedbush Is Cutting Fennec Pharmaceuticals Inc (FENC) Q4 18 Estimate To -0.16 From -0.12
8/14/2018 6:54:00 AM Wedbush Is Cutting Fennec Pharmaceuticals Inc (FENC) Q3 18 Estimate To -0.15 From -0.11
5/14/2018 3:59:50 PM Wedbush Is Raising Fennec Pharmaceuticals Inc (FENC) FY18 Estimate To -0.42 From -0.62
5/14/2018 3:59:39 PM Wedbush Is Increasing Fennec Pharmaceuticals Inc (FENC) Q4 18 Estimate To -0.12 From -0.17
5/14/2018 3:59:24 PM Wedbush Is Increasing Fennec Pharmaceuticals Inc (FENC) Q3 18 Estimate To -0.11 From -0.16